Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The CA125 Elimination rate constant K(KELIM) score correlates with intraoperative chemo-response score (CRS) in advanced ovarian cancer, potentially predicting treatment response.
Area Of Science
- Oncology
- Biochemistry
- Surgical Pathology
Background
- Advanced high-grade serous ovarian cancer (HGSC) necessitates effective neoadjuvant chemotherapy (NACT).
- Assessing treatment response during NACT is crucial for personalized therapy in HGSC.
Purpose Of The Study
- To evaluate the correlation between the pre-operative CA125 Elimination rate constant K (KELIM) score and the intraoperative chemo-response score (CRS).
- To determine if KELIM can predict pathological response in advanced HGSC patients undergoing NACT.
Main Methods
- Retrospective cohort study of 172 Stage III-IV HGSC patients treated with NACT.
- KELIM scores calculated using a validated online tool; CRS assessed via a 3-tier system.
- Association analysis to correlate KELIM and CRS scores.
Main Results
- A significant correlation was found between KELIM and CRS scores (p=0.0017).
- Patients with higher CRS (CRS3) and KELIM ≥1 showed significantly improved progression-free survival (PFS) (28.27 months).
- Lower KELIM (<1) was associated with poorer outcomes (lower PFI, PFS) in patients with CRS 1-2.
Conclusions
- The pre-operative KELIM score is a biochemical marker that correlates with the surgical pathologic CRS.
- KELIM may serve as a predictive tool for pathological response to neoadjuvant chemotherapy in advanced ovarian cancer.
- This correlation can aid in tailoring personalized treatment strategies for ovarian cancer patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
